Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $576 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $11.9K | $4.9K | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | −$11.9K | −$4.3K | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | -747.2% | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$17.0K | −$20.4K | −$8.4K | −$20.8K | −$13.9K | −$421.6K | −$10.7K | −$257.3K |
| EBITDA | −$17.0K | −$20.4K | −$8.4K | −$20.8K | −$13.9K | −$421.6K | −$10.8K | −$1.5M |
| Net income | −$17.0K | −$20.4K | −$8.4K | −$20.8K | −$13.9K | −$433.0K | −$10.8K | −$1.5M |
| Net margin | — | -3539.1% | — | — | — | — | — | — |
| EPS (diluted) | -0.24 | -0.16 | -0.07 | -0.16 | -0.11 | -0.09 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
ITOKK INC
No one on the platform currently holds IKTO.
No tracked institution reports a position in IKTO as of their last filing.
No one on the platform has traded IKTO yet.
| $8760 |
| — |
| DSAQDirect Selling Acquisition Corp. | $11.69 | +0.00% | $99M | — |
| IGSCIGS Capital Group Limited | $1.25 | -10.71% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$TRUFF.X 🔥 Every great story starts small – $TRUFF.X is that start. $UJOGF $IKTO $SOL.X
View on StockTwits ↗$IKTO .0002 Vs. Strickland company Worth a lottery play with the low O/S? GLTA 🕊️🕊️🕊️🕊️🕊️🕊️
View on StockTwits ↗$IKTO Any news? 👀👀 $VTGN expecting some news soon 🚀🚀🚀🚀
View on StockTwits ↗Congrats to everyone who invested in $IKTO is seeing great results! Up next, $VTGN is moving forward in Phase 3 with fasedienol, a nasal spray for social anxiety. PALISADE-3 and 4 are testing its effectiveness in reducing anxiety during public speaking challenges, showing fast and promising results
View on StockTwits ↗$ALT Looks like a squeeze is coming in power-hour. Im holding for a Buyout https://www.fool.com/investing/2024/08/09/prediction-this-weight-loss-stock-will-be-acquired/ Also watching: $SHOP $DJT $AZI $IKTO
View on StockTwits ↗$ALT Stock is running on great ER: https://ir.altimmune.com/news-releases/news-release-details/altimmune-announces-third-quarter-2024-financial-results-and Also watching: $SHOP $AZI $EVGO $IKTO
View on StockTwits ↗$ALT Big buy coming in, she about to explode. Ready for UBS tomorrow? And new data Friday? Also watching: $SHOP $TSHA $DJT $IKTO
View on StockTwits ↗$IKTO $FOXO Take a look at OLB Bitcoin mining sitting at an all time low Excellent numbers going into a crypto run this year and 2025 🔥🔥 Not a financial advice
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.